Hyaluronan inhibits IL-1β-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells

References

• Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activ-ity. Osteoarthr Cartil. 2005;13(3):216–24.
   PubMed Web of Science ®Google Scholar
• Julovi SM, Yasuda T, Shimizu M, Hiramitsu T, Nakamura T. Inhibition of interleukin-1 /3-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004;50(2):516–25.
   Google Scholar
• Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61(7):1303–13.
   Google Scholar
• Jeffery J. Interstitial collagenases. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. San Diego: Academic Press; 1998. p. 15–38.
   Google Scholar
• Shlopov By, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 1997;40(11):2065–74.
   PubMedGoogle Scholar
• Knduper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem. 1997;272(12):7608–16.
   Google Scholar
• Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinfiammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Associations with degenerative changes. Arthritis Rheum. 2001;44(3):585–94.
   Google Scholar
• Geng Y, Valbracht J, Lotz M. Selective activation of mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest. 1996;98(10):2425–30.
   Google Scholar
• Shikhman AR, Kuhn K, Alaaeddine NM, Lotz M. N-acetylglu-cosamine prevents IL-1-mediated activation of human chondrocytes. J Immunol. 2001;166(8):5155–60.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brine-kerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: dif-ferential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–11.
   Google Scholar
• Eder J. Tumor necrosis factor-a and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol Sci. 1997;18(9):319–22.
   PubMedGoogle Scholar
• Vincenti MP, Brinckerhoff CE. The potential of signal trans-duction inhibitors for the treatment of arthritis: is it all just JNK? J Clin Invest. 2001;108(2):181–3.
   PubMedGoogle Scholar
• Rutter JL, Benbow U, Coon CI, Brinckerhoff CE. Cell-type specific regulation of human interstitial collagense-1 gene expression by interleukin-1/3 (IL-1/3) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem. 1997;66(3):322–36.
   PubMedGoogle Scholar
• Pendas AM, Balbin M, Llano E, Jiménez MG, Lopez-06n C. Structural analysis and promoter characterization of human col-lagenase-3 gene (MMP-13). Genomics. 1997;40(2):222–33.
   Google Scholar
• Yasuda T, Julovi SM, Hiramitsu T, Yoshida M, Nakamura T. Requirement of mitogen-activated protein kinase for collagenase production by fibronectin fragment in human articular chondro-cytes in culture. Mod Rheumatol. 2004;14(1):54–60.
   Google Scholar
• Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi SM, Hiramitsu T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol. 2003;30(6):1164–72.
   PubMed Web of Science ®Google Scholar
• Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102(2):344–52.
   PubMed Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Laurent AE, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44(12):817–22.
   PubMed Web of Science ®Google Scholar
• Bonassar LJ, Frank EH, Murray JC, Paguio CG, Moore VL, Lark MW, et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum. 1995;38(2):173–83.
   PubMedGoogle Scholar
• Kempson GE. Mechanical properties of articular cartilage. In: Freeman MAR (ed) Adult articular cartilage. Tunbridge Wells: Pitman Medical; 1979. p. 333–414.
   Google Scholar
• Fosang AJ, Last K, Knduper V, Murphy G, Neame PJ. Degra-dation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 1996;380: 17–20.
   Google Scholar
• Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM, et al. Blocking aggrecanase cleavage in the aggrecan inter-globular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest. 2007;117(6):1627–36. Epub 2007 May 17.
   Google Scholar
• Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, et al. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol. 1997;158(7):3165–73.
   PubMedGoogle Scholar
• Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther. 1996;279(3):1453–61.
   PubMed Web of Science ®Google Scholar
• Pei Y, Harvey A, Yu XP, Chandrasekhar S, Thirunavukkarasu K. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthr Carta. 2006;14(8):749–58.
   Google Scholar
• Toba T, Mizusawa N, Tajima G, Horiuchu S. Upregulation of CD44 mRNA expression by interleukin-1/3 in cultured rabbit articular chondrocytes. J Bone Miner Metab. 1997;15:84–93.
   Google Scholar
• Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheuma-toid arthritis. Arthritis Rheum. 1999;42:659–68.
   PubMed Web of Science ®Google Scholar
• Ohno S, Im H.T, Knudson CB, Knudson W. Hyaluronan oligo-saccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum. 2005;52(3):800–9.
   PubMedGoogle Scholar
• Ohno S, Im HJ, Knudson CB, Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via tran-scriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem. 2006;281(26):17952–60.
   PubMedGoogle Scholar
• Tanaka M, Masuko-Hongo K, Kato T, Nishioka K, Nakamura H. Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes. Rheumatol Int. 2006;26(3):185–90.
   PubMed Web of Science ®Google Scholar
• Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molec-ular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteo-arthr Cartil. 2006;14(12):1237–47.
   Google Scholar
• Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol. 2006;16(4):197–205.
   PubMedGoogle Scholar
• Santangelo KS, Johnson AL, Ruppert AS, Bertone AL. Effects of hyaluronan treatment on lipopolysaccharide-challenged fibro-blast-like synovial cells. Arthritis Res Ther. 2007;9(1):R1.
   Google Scholar